Certified by Founder Lodge
Oak Hill Bio
- ND
START UP
1 Disclosed Funding Rounds $32,500,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Oak Hill Bio is a clinical-stage biotech company committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 05 ,2026 | Series A | $32,500,000 |
Balyasny Asset Management L.P.
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Scispot | $8,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
